D
BioCryst Pharmaceuticals, Inc. BCRX
$8.39 -$0.17-1.99% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 163.35M 145.53M 131.53M 117.09M 109.33M
Total Other Revenue -- -- -- -- 1.04M
Total Revenue 163.35M 145.53M 131.53M 117.09M 109.33M
Cost of Revenue 46.18M 41.84M 55.57M 44.31M 39.32M
Gross Profit 117.17M 103.70M 75.96M 72.78M 70.01M
SG&A Expenses 87.38M 82.47M 80.47M 65.08M 61.25M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 133.57M 124.31M 136.04M 109.39M 100.57M
Operating Income 29.79M 21.23M -4.51M 7.69M 8.76M
Income Before Tax 6.49M 758.00K -25.99M -13.45M -12.50M
Income Tax Expenses 1.40M 726.00K 804.00K 586.00K 172.00K
Earnings from Continuing Operations 5.09M 32.00K -26.80M -14.03M -12.67M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 5.09M 32.00K -26.80M -14.03M -12.67M
EBIT 29.79M 21.23M -4.51M 7.69M 8.76M
EBITDA 30.12M 21.56M -2.43M 8.00M 9.08M
EPS Basic 0.02 0.00 -0.13 -0.07 -0.06
Normalized Basic EPS 0.03 0.00 -0.08 -0.04 -0.04
EPS Diluted 0.02 0.00 -0.13 -0.07 -0.06
Normalized Diluted EPS 0.03 0.00 -0.08 -0.04 -0.04
Average Basic Shares Outstanding 209.52M 208.88M 207.38M 206.91M 206.43M
Average Diluted Shares Outstanding 219.89M 215.26M 207.38M 206.91M 206.43M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --